CNBX Pharmaceuticals (CNBX Pharmaceuticals) Receivables Turnover : 0.00 (As of Feb. 2024)

View and export this data going back to 2007. Start your Free Trial

What is CNBX Pharmaceuticals Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. CNBX Pharmaceuticals's Revenue for the three months ended in Feb. 2024 was $0.04 Mil. CNBX Pharmaceuticals's average Accounts Receivable for the three months ended in Feb. 2024 was $0.00 Mil.

CNBX Pharmaceuticals Receivables Turnover Historical Data

The historical data trend for CNBX Pharmaceuticals's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CNBX Pharmaceuticals Receivables Turnover Chart

CNBX Pharmaceuticals Annual Data

Trend

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Receivables Turnover

Get a 7-Day Free Trial

CNBX Pharmaceuticals Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Receivables Turnover	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of CNBX Pharmaceuticals's Receivables Turnover

For the Biotechnology subindustry, CNBX Pharmaceuticals's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CNBX Pharmaceuticals's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CNBX Pharmaceuticals's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where CNBX Pharmaceuticals's Receivables Turnover falls into.

CNBX Pharmaceuticals Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

CNBX Pharmaceuticals's Receivables Turnover for the fiscal year that ended in Aug. 2023 is calculated as

	Receivables Turnover (A: Aug. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Aug. 2023 )	/ (	(Accounts Receivable (A: Aug. 2022 )	+	Accounts Receivable (A: Aug. 2023 ))	/	count )
=	0.41	/ (	(0	+	0)	/	1 )
=	0.41	/	0
=	N/A

CNBX Pharmaceuticals's Receivables Turnover for the quarter that ended in Feb. 2024 is calculated as

	Receivables Turnover (Q: Feb. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Feb. 2024 )	/ (	(Accounts Receivable (Q: Nov. 2023 )	+	Accounts Receivable (Q: Feb. 2024 ))	/	count )
=	0.041	/ (	(0	+	0)	/	1 )
=	0.041	/	0
=	N/A

CNBX Pharmaceuticals (OTCPK:CNBX) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

CNBX Pharmaceuticals Receivables Turnover Related Terms

Thank you for viewing the detailed overview of CNBX Pharmaceuticals's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

CNBX Pharmaceuticals (CNBX Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CNBX Pharmaceuticals Inc (OTCPK:CNBX) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3 Bethesda Metro Center, Suite 700, Bethesda, MD, USA, 20814

Website

https://www.cnbxpharma.com

CNBX Pharmaceuticals Inc is a biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing HTS technology and personalized bioinformatics tools. The company's main focus is the development of cannabinoid therapies and other technologies for the treatment of cancer, mainly cancers of the gastrointestinal tract, skin, breast, and prostate. The firm's main product is the RCC-33, an oral capsule for the treatment of colorectal cancer. The company tools include delivery systems, personalized medicine diagnostics, and therapies based on Cannabinoid compounds.

Executives

Cannabics Inc.	10 percent owner	108 WEST 13TH ST., WILMINGTON DE 19801
Thomas E Mills	director, officer: President, CEO, CFO
North American Mining Corp	10 percent owner	6767 WEST TROPICANA AVENUE, SUITE 229, LAS VEGAS NV 89103
Lou Hilford	director, officer: Vice-President, Secretary